in Cancer Research

Mikhail Blagosklonny and the Anti-Aging Drug Formula

Rejuvenating immunity, anti-drug, are two of the most controversial topics in the world of medicine, coupling, in these two categories, many attempts at recreating some of the fairy tales about finding the cure for aging and the process of getting old.

However, these fairy tales aren’t that fairy at all, as some researches are getting to results for the last couple of years, and what seems to be happening is that science is reaching an anti-aging drug with a dedicated formula that promises to reduce and combat some of the true, major effects that come with getting older.

The solution for these years that ought to cause your body not to function as properly ten years from now was found by Dr. Mikhail V. Blagosklonny and his team of professionals. According to specialists, the year of 2014 was a true year of celebration for this side of medicine, with a clear finding showing its face on the horizon of many, many years to come when professionals would be developing one of the most promising scientific researches in the industry.

The discovery was introduced just now because of some misconceptions about aging that Mikhail V. Blagosklonny refuted during his years developing the anti-aging drug. According to the specialist, who has been more than a decade developing the formula, aging was thought to be a conglomeration of damage that naturally happens to the body while time passes, and simply cannot be prevented because it is damage that is inevitable.

Read more:

This is, although very self-explanatory, wrong, according to the expert. Aging is simply an extension of the process of growing up. It is part of the pre-defined DNA route that nature has in store for all living beings (well, some species of jellyfishes have surpassed the natural scheme of things), and Mikhail Blagosklonny thinks that knowing it is part of the genetic part of human beings, it is much more easily researchable and altered by physicians of the whole world. With a technical explanation given by the hyperfunction theory, the “getting old” process is caused by a group of pathways, like TOR (Target of Rapamycin).

While the physicians know that cell components like TOR are affecting these changes in the natural growth, Mikhail Blagosklonny has developed a method that is centered in the TOR and, with that, it can treat aging and prevent complications that arise with it.

Seems magical right? Although it is still in development and there is still a lot of research that needs to be conducted to fully develop the TOP-centric model, the Everolimus, a rapamycin analog, is showing extreme progress in what it promises to do: extending the life-time of humans and preventing diseases from occurring with aging.

According to another specialist that analyzed the work of Mikhail Blagosklonny, Nir Barzilai, the Everolimus targets every effect that comes with aging and improves the process in a way that it is revolutionary and a marking stone for the next scientific researches to come after it. Visit to know more about Mikhail

As any other big theory in the world of science, the anti-aging drug has been under development for more than it seems like, with its first few theories being publicly ridiculized for being “too childish” and “never going to work.” Now, past three years after its initial announcement in 2014, the drug is still growing strong as one of the most anticipated solutions for aging in the world, and the name “Mikhail Blagosklonny” has become extremely famous as a result.